BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Deals

Labopharm, Angelini deal

In July, companies said they would terminate their JV, Angelini Labopharm LLC, and Labopharm would transfer its 50% stake in the JV to Angelini. The JV was formed in May 2010 to market major depressive disorder (MDD) drug Oleptro trazodone in the U.S. Labopharm also will grant Angelini exclusive rights...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >